BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
181 – 190 of 3086
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men
- Contribution to journal › Article
-
Mark
Immunoprofiles of colorectal cancer from Lynch syndrome
- Contribution to journal › Article
-
Mark
Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients : predictors of testing uptake
- Contribution to journal › Article
-
Mark
Quality of Life After Open Radical Prostatectomy Compared with Robot-assisted Radical Prostatectomy
- Contribution to journal › Article
-
Mark
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE) : a cost minimisation analysis
- Contribution to journal › Article
-
Mark
Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer
- Contribution to journal › Article
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- Contribution to journal › Article
-
Mark
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re : Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961–7
- Contribution to journal › Letter
-
Mark
Clinical chemistry’s special issue on men’s health
- Contribution to journal › Debate/Note/Editorial
-
Mark
Is there a role for immunomodulatory drugs in the treatment of mantle cell lymphoma?
- Contribution to journal › Article
